New Tides review

New Tides' current FAQ (opens in a new tab) lists semaglutide at $200 and tirzepatide at $250 per prescription. It says that includes the physician consultation, medication, FedEx two-day delivery after pharmacy fulfillment and ongoing care-team messaging. The weight-management page (opens in a new tab) displays the same figures with monthly labels. Confirm the supplied quantity and expected duration before comparing them with another provider's monthly plan.

The terms (opens in a new tab) describe no membership or subscription and no automatic renewal. A card is saved at sign-up but charged only when the physician sends a prescription; the amount is shown before the card is provided. If treatment is not approved, it says the card is not charged. That billing model is different from a subscription that renews unless you cancel.

The terms say patients pay New Tides, which pays the pharmacy, so there should be no separate pharmacy bill for the included prescription. If the physician orders laboratory testing, its cost is disclosed before ordering. Do not treat an all-in medication price as proof that every possible laboratory test is free; our lab-cost guide explains the distinction.

The how-it-works page (opens in a new tab) says a prescribed dose change does not change the price. However, the reviewed public pages do not establish a precise quantity, concentration and supply period for every prescription. Ask for those details and the next expected charge before consenting to treatment, especially when comparing an injection with a different formulation.

The physician page (opens in a new tab) says the same physician starts the plan, adjusts the dose and answers messages. It says a video visit can be requested in any state and is included. The page describes physician qualifications but does not name the treating physician or provide an individual license number in the material reviewed. Obtain that identity before the consultation rather than treating a general qualification statement as verification.

The sourcing page (opens in a new tab) describes U.S.-licensed 503A compounding pharmacies and says partners are LegitScript certified. It does not identify the pharmacy assigned to an individual prescription. Request its legal name and location, then use the pharmacy verification checklist. These are provider disclosures; we have not independently verified those credentials or your eventual prescription.

The published service list (opens in a new tab) contains forty-five states and Washington, D.C. Illinois, Massachusetts, New Mexico, Oregon and Virginia are absent. The state selector contains additional options, so simply finding your state in that dropdown is not evidence that treatment is offered there. Patients must be at least eighteen and physically present in a served state for the visit.

The FAQ says some states require video evaluation and others allow an intake-based review; it also allows the physician to request a visit. Confirm the process for your location and treatment instead of treating an online questionnaire as a promised prescription. The public state page adds specific visit notes for several jurisdictions, which should be read alongside the FAQ.

The shipping and returns policy (opens in a new tab) says a prescription cannot be refunded once it has been sent to the pharmacy, even before it arrives. It offers a refund when a patient changes their mind before that transmission and says declined treatment is not charged. Stopping future care does not unwind a prescription already sent.

Orders are generally prepared and dispatched within a few business days after approval, with two-business-day transit counted from dispatch. Those are estimates rather than a delivery guarantee from the day of intake. For a damaged, significantly delayed or incorrect shipment, the policy describes a replacement at no charge rather than a refund. Keep the packaging and contact the team promptly; the warm-shipment guide explains why the dispensing pharmacy should advise on a questionable package.

The pay-per-prescription model may appeal to someone who does not want a subscription to renew in the background. Published lab-cost disclosure and the separation between preparation and shipping are useful details. The main gaps are the exact prescription quantity and the names of the clinician and dispensing pharmacy. Resolve those before payment; no automatic renewal does not make a prescription risk-free or refundable after it is sent.